Clinical Trials Browser

Not yet recruiting × Lymphoma, B-Cell, Marginal Zone × 90 days × Clear all

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07424833 2026-02-20

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Phase 1 Not yet recruiting

180 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07376330 2026-02-12

Molecular and Cellular Characterization of MALT Lymphoma

Not yet recruiting

400 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT07299331 2025-12-23

Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma

Phase NA Not yet recruiting

50 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

Clinical Trials

Archonc-001

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Molecular and Cellular Characterization of MALT Lymphoma

Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma